← All Genenta Science Spa filings

Genenta Science Spa 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
GNTA
Genenta Science Spa
20-F: Genenta Science S.p.A. Details Securities Registered Under Exchange Act in 20-F Filing
Genenta Science S.p.A. outlines its registered securities, including Ordinary Shares and American Depositary Shares (ADSs), as of December 31, 2024, in its latest 20-F filing.
NASDAQ
GNTA
Genenta Science Spa
20-F/A: Genenta Science Files Amendment to 20-F to Include Auditor Consent
Genenta Science S.p.A. filed an amendment to its annual report on Form 20-F for the fiscal year ended December 31, 2023, to include the consent of its independent registered public accounting firm, Dannible & McKee, LLP.
NASDAQ
GNTA
Genenta Science Spa
20-F: Genenta Science Reports Financial Results for Fiscal Year 2023
Genenta Science's Form 20-F filing reveals the company's financial performance for the year ended December 31, 2023, highlighting ongoing losses and reliance on future funding.